InvestorsHub Logo
Followers 233
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Wednesday, 10/16/2013 11:53:13 AM

Wednesday, October 16, 2013 11:53:13 AM

Post# of 429367
IMO the FDA is doing everything possible to torpedo this. The absence of a safety data presentation is absolutely incompetent when asking members to vote. Then FDA Dr. Smith reviews to the World the FDA considered safety moot because Vascepa is not a NME. Whether he was referring to it being already approved or comparing it to Lovaza is unknown.

Not a surprise our Government is planning to default tomorrow.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News